Published in Cancer Cell on April 14, 2014
Tumour exosome integrins determine organotropic metastasis. Nature (2015) 4.09
Targeting metastasis-initiating cells through the fatty acid receptor CD36. Nature (2016) 2.11
Exosomes released by chronic lymphocytic leukemia cells induce the transition of stromal cells into cancer-associated fibroblasts. Blood (2015) 1.70
Exosome and exosomal microRNA: trafficking, sorting, and function. Genomics Proteomics Bioinformatics (2015) 1.65
Radiation-induced miR-208a increases the proliferation and radioresistance by targeting p21 in human lung cancer cells. J Exp Clin Cancer Res (2016) 1.46
Breast-cancer-secreted miR-122 reprograms glucose metabolism in premetastatic niche to promote metastasis. Nat Cell Biol (2015) 1.44
Exosomal microRNA miR-92a concentration in serum reflects human brown fat activity. Nat Commun (2016) 1.40
Exosome-delivered microRNAs modulate the inflammatory response to endotoxin. Nat Commun (2015) 1.39
Brain metastatic cancer cells release microRNA-181c-containing extracellular vesicles capable of destructing blood-brain barrier. Nat Commun (2015) 1.37
Metastatic colonization by circulating tumour cells. Nature (2016) 1.31
Exosomes in cancer: small particle, big player. J Hematol Oncol (2015) 1.29
Differential fates of biomolecules delivered to target cells via extracellular vesicles. Proc Natl Acad Sci U S A (2015) 1.27
Human bone marrow- and adipose-mesenchymal stem cells secrete exosomes enriched in distinctive miRNA and tRNA species. Stem Cell Res Ther (2015) 1.21
Exosomes as divine messengers: are they the Hermes of modern molecular oncology? Cell Death Differ (2014) 1.18
MicroRNAs as mediators and communicators between cancer cells and the tumor microenvironment. Oncogene (2015) 1.16
Exosome-mediated transfer of miR-10b promotes cell invasion in breast cancer. Mol Cancer (2014) 1.15
Tumor-secreted miR-214 induces regulatory T cells: a major link between immune evasion and tumor growth. Cell Res (2014) 1.11
Cross-kingdom inhibition of breast cancer growth by plant miR159. Cell Res (2016) 1.07
The Roles of MicroRNAs in Breast Cancer. Cancers (Basel) (2015) 1.06
The biology and function of exosomes in cancer. J Clin Invest (2016) 1.04
Exosomes serve as tumour markers for personalized diagnostics owing to their important role in cancer metastasis. J Extracell Vesicles (2015) 1.02
Regulation of cancer metastasis by cell-free miRNAs. Biochim Biophys Acta (2014) 1.02
Extracellular vesicle transfer of cancer pathogenic components. Cancer Sci (2016) 1.01
Fibroblast-Derived Exosomes Contribute to Chemoresistance through Priming Cancer Stem Cells in Colorectal Cancer. PLoS One (2015) 0.98
The impact of extracellular vesicle-encapsulated circulating microRNAs in lung cancer research. Biomed Res Int (2014) 0.96
The fusion of two worlds: non-coding RNAs and extracellular vesicles--diagnostic and therapeutic implications (Review). Int J Oncol (2014) 0.93
Insights into the key roles of proteoglycans in breast cancer biology and translational medicine. Biochim Biophys Acta (2015) 0.92
Versatile roles of extracellular vesicles in cancer. J Clin Invest (2016) 0.92
Directly visualized glioblastoma-derived extracellular vesicles transfer RNA to microglia/macrophages in the brain. Neuro Oncol (2015) 0.92
Biogenesis, delivery, and function of extracellular RNA. J Extracell Vesicles (2015) 0.92
Tumor-penetrating iRGD peptide inhibits metastasis. Mol Cancer Ther (2014) 0.91
Induction of miRNA-181a by genotoxic treatments promotes chemotherapeutic resistance and metastasis in breast cancer. Oncogene (2015) 0.91
Exosome proteomics reveals transcriptional regulator proteins with potential to mediate downstream pathways. Cancer Sci (2014) 0.91
Distinctive properties of metastasis-initiating cells. Genes Dev (2016) 0.91
Surviving at a distance: organ specific metastasis. Trends Cancer (2015) 0.90
Signaling by exosomal microRNAs in cancer. J Exp Clin Cancer Res (2015) 0.90
MicroRNAs in glioblastoma multiforme pathogenesis and therapeutics. Cancer Med (2016) 0.89
Diagnostic, prognostic and predictive value of cell-free miRNAs in prostate cancer: a systematic review. Mol Cancer (2016) 0.89
Metastatic breast cancer: the potential of miRNA for diagnosis and treatment monitoring. Cancer Metastasis Rev (2015) 0.88
Exosomes in development, metastasis and drug resistance of breast cancer. Cancer Sci (2015) 0.87
Interactions between cancer cells and normal cells via miRNAs in extracellular vesicles. Cell Mol Life Sci (2015) 0.87
The Role of Extracellular Vesicles: An Epigenetic View of the Cancer Microenvironment. Biomed Res Int (2015) 0.86
Exosomic microRNAs in the Tumor Microenvironment. Front Med (Lausanne) (2015) 0.85
MicroRNA-99a inhibits tumor aggressive phenotypes through regulating HOXA1 in breast cancer cells. Oncotarget (2015) 0.85
Extracellular Vesicles in Cancer: Cell-to-Cell Mediators of Metastasis. Cancer Cell (2016) 0.85
Cancer-associated fibroblast exosomes regulate survival and proliferation of pancreatic cancer cells. Oncogene (2016) 0.84
The potential of microRNAs in personalized medicine against cancers. Biomed Res Int (2014) 0.84
MicroRNA-92b represses invasion-metastasis cascade of esophageal squamous cell carcinoma. Oncotarget (2016) 0.84
The role of EMT and MET in cancer dissemination. Connect Tissue Res (2015) 0.84
microRNAs as Potential Biomarkers in Adrenocortical Cancer: Progress and Challenges. Front Endocrinol (Lausanne) (2016) 0.84
A novel cancer-germline transcript carrying pro-metastatic miR-105 and TET-targeting miR-767 induced by DNA hypomethylation in tumors. Epigenetics (2014) 0.83
MicroRNA as new tools for prostate cancer risk assessment and therapeutic intervention: results from clinical data set and patients' samples. Biomed Res Int (2014) 0.83
Clinical relevance of circulating cell-free microRNAs in ovarian cancer. Mol Cancer (2016) 0.83
The roles of microRNAs in the regulation of tumor metastasis. Cell Biosci (2015) 0.82
miR-15b and miR-21 as Circulating Biomarkers for Diagnosis of Glioma. Curr Genomics (2015) 0.81
Physical nanoscale conduit-mediated communication between tumour cells and the endothelium modulates endothelial phenotype. Nat Commun (2015) 0.81
miR-509 suppresses brain metastasis of breast cancer cells by modulating RhoC and TNF-α. Oncogene (2015) 0.81
MicroRNAs regulate tight junction proteins and modulate epithelial/endothelial barrier functions. Tissue Barriers (2014) 0.81
The Multiple Roles of Exosomes in Metastasis. Cancer Genomics Proteomics (2016) 0.81
High-grade ovarian cancer secreting effective exosomes in tumor angiogenesis. Int J Clin Exp Pathol (2015) 0.81
The functions and clinical applications of tumor-derived exosomes. Oncotarget (2016) 0.81
Role for extracellular vesicles in the tumour microenvironment. Philos Trans R Soc Lond B Biol Sci (2018) 0.81
Tumor exosome-mediated promotion of adhesion to mesothelial cells in gastric cancer cells. Oncotarget (2016) 0.81
MicroRNAs in extracellular vesicles: potential cancer biomarkers. J Hum Genet (2016) 0.81
Extracellular Vesicles: Role in Inflammatory Responses and Potential Uses in Vaccination in Cancer and Infectious Diseases. J Immunol Res (2015) 0.80
Obstacles and opportunities in the functional analysis of extracellular vesicle RNA - an ISEV position paper. J Extracell Vesicles (2017) 0.80
Functional role of extracellular vesicles and lipoproteins in the tumour microenvironment. Philos Trans R Soc Lond B Biol Sci (2018) 0.80
Increasing the immune activity of exosomes: the effect of miRNA-depleted exosome proteins on activating dendritic cell/cytokine-induced killer cells against pancreatic cancer. J Zhejiang Univ Sci B (2016) 0.80
miRNAs and Other Epigenetic Changes as Biomarkers in Triple Negative Breast Cancer. Int J Mol Sci (2015) 0.80
A MicroRNA Expression Signature In Taxane-anthracycline-Based Neoadjuvant Chemotherapy Response. J Cancer (2015) 0.80
Essential role of miRNAs in orchestrating the biology of the tumor microenvironment. Mol Cancer (2016) 0.80
Exosome-derived microRNAs in cancer metabolism: possible implications in cancer diagnostics and therapy. Exp Mol Med (2017) 0.79
Targeting oncomiRNAs and mimicking tumor suppressor miRNAs: Νew trends in the development of miRNA therapeutic strategies in oncology (Review). Int J Oncol (2016) 0.79
Cancer genetics: Exosomally derived miR-105 destroys tight junctions. Nat Rev Genet (2014) 0.79
Decoding the Secret of Cancer by Means of Extracellular Vesicles. J Clin Med (2016) 0.79
Identification of low miR-105 expression as a novel poor prognostic predictor for human glioma. Int J Clin Exp Med (2015) 0.79
MicroRNAs as paracrine signaling mediators in cancers and metabolic diseases. Best Pract Res Clin Endocrinol Metab (2016) 0.78
Genetics: exosomally derived miR-105 destroys tight junctions. Nat Rev Cancer (2014) 0.78
Extracellular miR-1246 promotes lung cancer cell proliferation and enhances radioresistance by directly targeting DR5. Oncotarget (2016) 0.78
Tracking miRNAs' footprints in tumor-microenvironment interactions: Insights and implications for targeted cancer therapy. Genes Chromosomes Cancer (2015) 0.78
Emerging roles of exosomes in cancer invasion and metastasis. BMB Rep (2016) 0.78
Macrophage PPARγ inhibits Gpr132 to mediate the anti-tumor effects of rosiglitazone. Elife (2016) 0.78
Special delivery: microRNA-200-containing extracellular vesicles provide metastatic message to distal tumor cells. J Clin Invest (2014) 0.78
Functional Roles for Exosomal MicroRNAs in the Tumour Microenvironment. Comput Struct Biotechnol J (2016) 0.77
Exosomes in carcinogenesis: molecular palkis carry signals for the regulation of cancer progression and metastasis. J Cell Commun Signal (2016) 0.77
Sources and Functions of Extracellular Small RNAs in Human Circulation. Annu Rev Nutr (2016) 0.77
Exosome-mediated delivery of miR-9 induces cancer-associated fibroblast-like properties in human breast fibroblasts. Cell Death Dis (2016) 0.77
Exploring miRNA-Associated Signatures with Diagnostic Relevance in Glioblastoma Multiforme and Breast Cancer Patients. J Clin Med (2015) 0.77
MicroRNA in Metabolic Re-Programming and Their Role in Tumorigenesis. Int J Mol Sci (2016) 0.77
Exosomes: novel implications in diagnosis and treatment of gastrointestinal cancer. Langenbecks Arch Surg (2016) 0.76
Proteinase-activated Receptor 2 Promotes Cancer Cell Migration through RNA Methylation-mediated Repression of miR-125b. J Biol Chem (2015) 0.76
A functional extracellular transcriptome in animals? Implications for biology, disease and medicine. Genome Biol (2015) 0.76
Blocking of targeted microRNAs from next-generation sequencing libraries. Nucleic Acids Res (2015) 0.76
Circulating miRNA profile in esophageal adenocarcinoma. Am J Cancer Res (2016) 0.76
Transferring intercellular signals and traits between cancer cells: extracellular vesicles as "homing pigeons". Cell Commun Signal (2016) 0.76
Minireview: Emerging Roles for Extracellular Vesicles in Diabetes and Related Metabolic Disorders. Mol Endocrinol (2015) 0.76
Breast Cancer-Derived Extracellular Vesicles: Characterization and Contribution to the Metastatic Phenotype. Biomed Res Int (2015) 0.76
Exosomal microRNA Biomarkers: Emerging Frontiers in Colorectal and Other Human Cancers. Expert Rev Mol Diagn (2016) 0.76
Therapeutic implications of cellular and molecular biology of cancer stem cells in melanoma. Mol Cancer (2017) 0.75
Exosomes in cancer theranostic: Diamonds in the rough. Cell Adh Migr (2017) 0.75
MicroRNA signatures in human cancers. Nat Rev Cancer (2006) 46.29
Exosome-mediated transfer of mRNAs and microRNAs is a novel mechanism of genetic exchange between cells. Nat Cell Biol (2007) 37.10
Circulating microRNAs as stable blood-based markers for cancer detection. Proc Natl Acad Sci U S A (2008) 33.65
MicroRNA gene expression deregulation in human breast cancer. Cancer Res (2005) 27.56
Glioblastoma microvesicles transport RNA and proteins that promote tumour growth and provide diagnostic biomarkers. Nat Cell Biol (2008) 19.86
Dissemination and growth of cancer cells in metastatic sites. Nat Rev Cancer (2002) 17.49
VEGFR1-positive haematopoietic bone marrow progenitors initiate the pre-metastatic niche. Nature (2005) 15.57
Exosomes: composition, biogenesis and function. Nat Rev Immunol (2002) 13.99
Isolation and characterization of exosomes from cell culture supernatants and biological fluids. Curr Protoc Cell Biol (2006) 13.29
The distribution of secondary growths in cancer of the breast. 1889. Cancer Metastasis Rev (1989) 13.15
MicroRNA signatures of tumor-derived exosomes as diagnostic biomarkers of ovarian cancer. Gynecol Oncol (2008) 11.46
Melanoma exosomes educate bone marrow progenitor cells toward a pro-metastatic phenotype through MET. Nat Med (2012) 11.14
Argonaute2 complexes carry a population of circulating microRNAs independent of vesicles in human plasma. Proc Natl Acad Sci U S A (2011) 10.56
MicroRNAs are transported in plasma and delivered to recipient cells by high-density lipoproteins. Nat Cell Biol (2011) 8.21
Characterization of extracellular circulating microRNA. Nucleic Acids Res (2011) 6.24
Secreted monocytic miR-150 enhances targeted endothelial cell migration. Mol Cell (2010) 5.77
Seeding and propagation of untransformed mouse mammary cells in the lung. Science (2008) 5.33
The metastatic niche: adapting the foreign soil. Nat Rev Cancer (2009) 5.28
MicroRNAs bind to Toll-like receptors to induce prometastatic inflammatory response. Proc Natl Acad Sci U S A (2012) 5.07
Circulating microRNAs as novel minimally invasive biomarkers for breast cancer. Ann Surg (2010) 4.59
Regulation of in situ to invasive breast carcinoma transition. Cancer Cell (2008) 4.46
Exosomes mediate stromal mobilization of autocrine Wnt-PCP signaling in breast cancer cell migration. Cell (2012) 4.29
Systematic evaluation of microRNA processing patterns in tissues, cell lines, and tumors. RNA (2007) 3.91
HER2 kinase domain mutation results in constitutive phosphorylation and activation of HER2 and EGFR and resistance to EGFR tyrosine kinase inhibitors. Cancer Cell (2006) 3.73
Exosomes released by melanoma cells prepare sentinel lymph nodes for tumor metastasis. Cancer Res (2011) 3.73
Selective release of microRNA species from normal and malignant mammary epithelial cells. PLoS One (2010) 3.50
MCF10DCIS.com xenograft model of human comedo ductal carcinoma in situ. J Natl Cancer Inst (2000) 3.44
Improved targeting of miRNA with antisense oligonucleotides. Nucleic Acids Res (2006) 3.43
Crosstalk of tight junction components with signaling pathways. Biochim Biophys Acta (2007) 3.04
Circulating microRNAs as blood-based markers for patients with primary and metastatic breast cancer. Breast Cancer Res (2010) 2.98
Circulating microRNAs in breast cancer and healthy subjects. BMC Res Notes (2009) 2.78
Structural and functional regulation of tight junctions by RhoA and Rac1 small GTPases. J Cell Biol (1998) 2.75
Unravelling the complexity of metastasis - molecular understanding and targeted therapies. Nat Rev Cancer (2011) 2.64
Transfer of microRNAs by embryonic stem cell microvesicles. PLoS One (2009) 2.64
Myosin light chain phosphorylation regulates barrier function by remodeling tight junction structure. J Cell Sci (2006) 2.59
CCL2 mediates cross-talk between cancer cells and stromal fibroblasts that regulates breast cancer stem cells. Cancer Res (2012) 2.50
Tumour-secreted miR-9 promotes endothelial cell migration and angiogenesis by activating the JAK-STAT pathway. EMBO J (2012) 2.21
Pulmonary vascular destabilization in the premetastatic phase facilitates lung metastasis. Cancer Res (2009) 1.99
Loss of tight junction barrier function and its role in cancer metastasis. Biochim Biophys Acta (2008) 1.95
Transforming growth factor-β regulates the sphere-initiating stem cell-like feature in breast cancer through miRNA-181 and ATM. Oncogene (2010) 1.92
Lipid-based carriers of microRNAs and intercellular communication. Curr Opin Lipidol (2012) 1.73
The requirement for fibroblasts in angiogenesis: fibroblast-derived matrix proteins are essential for endothelial cell lumen formation. Mol Biol Cell (2011) 1.70
Rac regulates endothelial morphogenesis and capillary assembly. Mol Biol Cell (2002) 1.62
Metastatic breast cancer: an updating. Biomed Pharmacother (2006) 1.56
Plasma microRNA 210 levels correlate with sensitivity to trastuzumab and tumor presence in breast cancer patients. Cancer (2011) 1.53
Competitive interactions of cancer cells and normal cells via secretory microRNAs. J Biol Chem (2011) 1.48
De novo sequencing of circulating miRNAs identifies novel markers predicting clinical outcome of locally advanced breast cancer. J Transl Med (2012) 1.40
Modulation of TLR2 protein expression by miR-105 in human oral keratinocytes. J Biol Chem (2009) 1.35
Loss of tight junction plaque molecules in breast cancer tissues is associated with a poor prognosis in patients with breast cancer. Eur J Cancer (2004) 1.34
Cell-to-cell miRNA transfer: from body homeostasis to therapy. Pharmacol Ther (2012) 1.27
The organization of tight junctions in epithelia: implications for mammary gland biology and breast tumorigenesis. J Mammary Gland Biol Neoplasia (2003) 1.18
Context-dependent bidirectional regulation of the MutS homolog 2 by transforming growth factor β contributes to chemoresistance in breast cancer cells. Mol Cancer Res (2010) 1.16
Membrane-type 1 matrix metalloproteinase expression is regulated by zonula occludens-1 in human breast cancer cells. Cancer Res (2005) 1.09
Regulation of small GTPases at epithelial cell-cell junctions. Mol Membr Biol (2011) 1.06
Tight junctions: a barrier to the initiation and progression of breast cancer? J Biomed Biotechnol (2009) 1.01
The tight junction associated signalling proteins ZO-1 and ZONAB regulate retinal pigment epithelium homeostasis in mice. PLoS One (2010) 0.99
Homo sapiens systemic RNA interference-defective-1 transmembrane family member 1 (SIDT1) protein mediates contact-dependent small RNA transfer and microRNA-21-driven chemoresistance. J Biol Chem (2011) 0.98
miR-105 inhibits prostate tumour growth by suppressing CDK6 levels. PLoS One (2013) 0.94
Visceral disease in patients with metastatic breast cancer: efficacy and safety of treatment with ixabepilone and other chemotherapeutic agents. Clin Breast Cancer (2010) 0.90
7. Management of advanced breast cancer. Int J Clin Pract (2001) 0.87